EDHF: The Complete Story

Published:
Author(s):

Purchasing Options

Hardback
$199.95
Add to cart
ISBN 9780415332927
Cat# TF1758
 

Features

  • Highlights 25 years of research into the EDHF offering much new insight
  • Summarizes the work of many scientists, bringing closure to a long misunderstood topic
  • Offers original diagrams and schematics that summarize the different steps of endothelium-dependent hyperpolarization,
  • Summary

    The advances made in vascular biology in the last 25 years have considerably changed the perception that one could have of the endothelial cells. Once considered as a diffusion barrier preventing the access of the blood cells to the vascular matrix, the endothelium is now recognized as playing a major role in the control of blood fluidity, platelet aggregation, and vascular tone, but also in immunology, inflammation, angiogenesis, and for serving as a metabolizing and an endocrine organ.

    -- from the preface

    Cardiovascular diseases, so prevalent in the Western world during the twentieth century, could well become the scourge of the twenty-first century in emerging countries as well as the West. Endothelial dysfunction linked to an imbalance in the synthesis and/or release of contracting and relaxing factors is often evoked to explain the initiation of the cardiovascular pathology or its development and perpetuation. Two decades ago, when nitric oxide was demonstrated to mediate endothelium-dependent relaxations, the vascular world seemed convinced that nitric oxide was the ultimate and sole explanation for such relaxations. However not everyone agreed.

    EDHF: The Complete Story is the work of two leading researchers who did not accept that simple conclusion, but instead continued to search, along with others, for a deeper understanding of the ways in which endothelial cells communicate with the underlying smooth muscle to signal it to hyperpolarize. Now with most, if not all, of those ways, uncovered, the authors offer this summary as way of bringing closure to the quest.

    This monograph reports on the work of many researchers. It summarizes the significant recent discoveries concerning endothelium-dependent hyperpolarizations, which are likely to play a much more important role in cardiovascular physiology and pathology than was originally foreseen

    Extensively illustrated with original diagrams and schematics that summarize the different steps of endothelium-dependent hyperpolarization, the text is designed for vascular biologists, and cardiologists, as well as graduate students looking to gain an understanding of the intimate functioning of the blood vessel wall.

    Table of Contents

    THE BLOOD VESSEL WALL
    Multiple Functions of the Endothelial Cells
    Vascular Smooth Muscle
    Membrane Potential and Calcium Homeostasis in Vascular Smooth
    Muscle and Endothelial Cells
    ENDOTHELIUM-DERIVED MEDIATORS
    Metabolism of Arachidonic Acid
    Nitric Oxide Synthases
    The Other Endothelium-Derived Vasoactive Factors
    ENDOTHELIUM-DEPENDENT HYPERPOLARIZATIONS
    The Third Pathway: Historical Notes
    Prostacyclin
    Nitric Oxide
    Endothelium-Dependent Hyperpolarizations: Involvement of Calcium-Activated Potassium Channels
    Identification of the Potassium Channels Involved in EDHF-Mediated Responses
    Endothelium-Dependent Hyperpolarization: Localization of the Potassium Channels
    IKCa, SKCa, and Endothelial Hyperpolarization
    Beyond Endothelial Hyperpolarization
    Conclusion
    EDHF-Mediated Responses in Human Blood Vessels
    EDHF AND THE PHYSIOLOGICAL CONTROL OF BLOOD FLOW
    NOS-3 Knock-Out Mice
    EDHF and Arterial Blood Pressure
    Flow-Induced Vasodilatation
    Conducted Vasodilatation
    Vasomotion
    Hypoxia
    Exercise
    EDHF and Gender
    Pregnancy
    EDHF AND ENDOTHELIAL DYSFUNCTION
    Hypertension
    Aging
    Eclampsia
    Atherosclerosis and Hypercholesterolemia
    Heart Failure
    Ischemia-Reperfusion
    Angioplasty
    Transplantation
    Diabetes
    Sepsis
    Cancer
    Lead Intoxication
    EDHF AND THERAPEUTIC INTERVENTIONS
    Angiotensin-Converting Enzyme Inhibitors and Antagonists of the AT1-Angiotensin Receptor (AT1)
    Diuretics
    Calcium Channel Blockers
    -Adrenoceptor Blockers
    Statins
    ET-A Receptor Antagonists
    Anti-Diabetic Drugs
    Anesthetics
    Dietary Supplementation
    Exercise
    CONCLUSIONS
    REFERENCES

    Related Titles